Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...

Losing weight after a years-long struggle, this letter writer gave credit to the method — then came the judgmental comments.

Outfit? Check. Glassy skin? Check. Glam life as a bridal stylist with a quarter of a million TikTok followers? Check. In so ...

Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Among patients with diabetes who underwent PCI after an acute heart attack, those taking a GLP-1 had better survival rates ...

New research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in ...

For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can naturally mimic the effects of semaglutides.

Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being ...

GLP-1 drugs like Wegovy and Ozempic are designed to treat type 2 diabetes, but are widely known for their effect on weight ...

GLP-1 RAs were associated with significant reductions in body weight, BMI, and waist circumference among pediatric patients with obesity.